Fresenius Medical Care AG

Fresenius Medical Care is a healthcare company specializing in dialysis and renal care. The enterprise operates primarily across two operational business segments: Care Delivery and Care Enablement, while also engaging in value-based care initiatives. Through these segments, the organization provides comprehensive healthcare services as well as specialized healthcare products. Its clinical activities encompass dialysis care and associated renal treatments, while product offerings consist of dialysis machinery, healthcare equipment, and related supplies. Key customers include dialysis patients, healthcare providers, and public healthcare programs, notably U.S. Medicare and Medicaid.

The company maintains an extensive global presence across diverse geographic markets. Its business footprint spans the United States and international locations, including operations and legal entities established in Germany, France, the United Kingdom, Spain, Portugal, Poland, Romania, Australia, China, and South Korea. Corporate legal entities, associated credit facilities, and primary corporate disclosures indicate significant governance and corporate headquarters operations situated in Germany.

Summary of the business section of Fresenius Medical Care's latest annual report, written by StockData.

“At December 31, 2025, we had 109,698 employees (total headcount) as compared to 111,513 at December 31, 2024 and 119,845 at December 31, 2023.”